Source: Basic & Clinical Pharmacology & Toxicology. Unidade: FMRP
Subjects: CANABINOIDES, EPILEPSIA, DOENÇA DE PARKINSON, COMORBIDADE, PSIQUIATRIA
ABNT
SAMPAIO, Maria de Fátima dos Santos et al. Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson s disease and in comorbidity with psychiatric disorders. Basic & Clinical Pharmacology & Toxicology, v. 134, n. 5, p. 574-601, 2024Tradução . . Disponível em: https://doi.org/10.1111/bcpt.13997. Acesso em: 08 mar. 2026.APA
Sampaio, M. de F. dos S., Paiva, Y. B. de, Sampaio, T. B., Pereira, M. G., & Coimbra, N. C. (2024). Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson s disease and in comorbidity with psychiatric disorders. Basic & Clinical Pharmacology & Toxicology, 134( 5), 574-601. doi:10.1111/bcpt.13997NLM
Sampaio M de F dos S, Paiva YB de, Sampaio TB, Pereira MG, Coimbra NC. Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson s disease and in comorbidity with psychiatric disorders [Internet]. Basic & Clinical Pharmacology & Toxicology. 2024 ; 134( 5): 574-601.[citado 2026 mar. 08 ] Available from: https://doi.org/10.1111/bcpt.13997Vancouver
Sampaio M de F dos S, Paiva YB de, Sampaio TB, Pereira MG, Coimbra NC. Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson s disease and in comorbidity with psychiatric disorders [Internet]. Basic & Clinical Pharmacology & Toxicology. 2024 ; 134( 5): 574-601.[citado 2026 mar. 08 ] Available from: https://doi.org/10.1111/bcpt.13997
